CloudMD Stock: This Telehealth Company Is Poised for Huge Growth

CloudMD Software & Services (TSXV:DOC) stock is one of the best plays in the Canadian telemedicine sector right now. The company is growing very fast.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Telemedicine is hot and will stay strong for years. Evidence from a four-month pandemic in North America, when telemedicine was forced upon us, suggests that most patients find it as good, if not better, than in-person visits. Going to the doctor takes time and logistical preparation and incurs additional expenses. A half-hour date can turn into a much longer ordeal. CloudMD Software & Services (TSXV:DOC) is ideally positioned to grow rapidly in the field of telemedicine and potentially be acquired. CloudMD stock has a market cap of $233.5 million.

The telehealth company is revolutionizing the delivery of healthcare by giving patients quick and easy access to all aspects of their care via phone, tablet, laptop, or desktop.

Cloud MD offers SAAS (software as a service)-based health technology solutions to medical clinics across Canada and has developed proprietary technology that delivers quality health care through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI).

The company currently provides services to 376 clinics in eight provinces, over 3,000 licensed practitioners, and nearly 3 million patients.

CloudMD stock has profited from the pandemic

The SaaS-based healthcare technology company has been able to capitalize on the current pandemic crisis, with more and more patients turning to online consultations. CloudMD stock has soared more than 200% since its debut at TSXV in June of this year. Shares have increased by 130% in one month. The current price/book ratio (P/B) is 10.28.

CloudMD aims to tap the untapped $10 trillion virtual care market and focuses on an easily scalable vertical growth strategy with low overhead. It has also recently entered the U.S. markets.

The solutions offered by CloudMD include Telemedicine Platform, Medical Clinics, Cloud Practice which offers cloud-based Electronic Medical Records (EMRs), and pharmacy services.

CloudMD has the potential to be a stable, high margin, and fast-growing company with sustainable revenues.

CloudMD reported 163% year-over-year revenue growth in the second quarter. Its total revenue was $2,789,987, compared to $1,061,569 in Q2 2019. Growth was driven by telehealth and acquisitions.

Net loss and comprehensive loss was $2,768,117 in the second quarter, resulting in a net loss of $0.03 per share (basic and diluted).

In fiscal 2021, CloudMD is expected to increase its revenue by 124.4% to $37 million while earnings per share are estimated to grow at a rate of 100% to hit $0.00.

CloudMD is expanding in the U.S. market

CloudMD entered into a binding agreement in August to acquire 100% of a U.S.-based medical clinic serving patients with chronic illnesses. This acquisition is part of CloudMD’s broader strategy to enter the U.S. market with its full line of telehealth products.

This acquisition is an important and strategic part of CloudMD’s cross-border expansion plan in the United States. One of CloudMD’s primary goals with this acquisition is to begin providing a one-stop-shop for longitudinal care for chronic and complex patients in the U.S. These patients often suffer from multiple concurrent illnesses such as diabetes, hypertension, vascular and heart disease.

The opportunity for expansion with this acquisition is significant, as in the United States alone, 90% of the $3.5 trillion spent annually on healthcare is for chronic pain and mental health issues. CloudMD’s integrated telehealth technology will be used in clinical practice to ensure patient-centered continuity of care.

Should you invest $1,000 in CloudMD Software & Services right now?

Before you buy stock in CloudMD Software & Services, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and CloudMD Software & Services wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

See the Top Stocks * Returns as of 2/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned.

If You Thought Apple and Microsoft Were Big, You Need to Read This.

The steel industry produced the world's first $1 billion company in 1901, and it wasn't until 117 years later that technology giant Apple became the first-ever company to reach a $1 trillion valuation.

But what if I told you artificial intelligence (AI) is about to accelerate the pace of value creation? AI has the potential to produce several trillion-dollar companies in the future, and The Motley Fool is watching one very closely right now.

Don't fumble this potential wealth-building opportunity by navigating it alone. The Motley Fool has a proven track record of picking revolutionary growth stocks early, from Netflix to Amazon, so become a premium member today.

See the 'AI Supercycle' Stock

More on Tech Stocks

cloud computing
Tech Stocks

Alert: 2 High-Tech TFSA Growth Stars You Won’t Want to Miss

Shopify (TSX:SHOP) and a magnificent tech stock are worth buying for one's TFSA for the next few years.

Read more »

Data center woman holding laptop
Tech Stocks

Why CGI Stock Could Be the Best Stock to Buy Right Now

CGI has a strong long-term history of shareholder value generation, operational performance, and stock price gains.

Read more »

Digital background depicting innovative technologies in (AI) artificial systems, neural interfaces and internet machine learning technologies
Tech Stocks

The Savviest U.S. Stock to Buy With $5,000 Right Now  

The AI rally is not dead, and this AI-savvy U.S. stock could prove this in 2025 with its upcoming product…

Read more »

A patient takes medicine out of a daily pill box.
Tech Stocks

The Best AI Stock to Invest $1,000 in Right Now

It's had its ups and downs, but WELL Health stock is making a comeback in a big way among AI…

Read more »

grow money, wealth build
Tech Stocks

Canadian Stocks That Could Create Lasting Generational Wealth

Build a rich retirement portfolio and create a wealth legacy with Shopify and another esteemed growth stock

Read more »

A worker gives a business presentation.
Tech Stocks

1 Essential “Magnificent 7” Stock for Canadian Portfolios

Apple (NASDAQ:AAPL) stands out as an intriguing Magnificent Seven stock worth Canadians' investment dollars.

Read more »

Canada day banner background design of flag
Dividend Stocks

The Canadian Stocks That Led Their Sectors in 2024

Four Canadian stocks that topped their sectors in 2024 are likely to carry over their momentum this year.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

How to Invest in Canadian Stocks for Long-Term Gains

Wondering how to earn long-term gains in Canadian stocks? Here's one strategy that can really deliver over time.

Read more »